Alvotech Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Robert Wessman
Chief executive officer
US$1.5m
Total compensation
CEO salary percentage | 98.3% |
CEO tenure | 1.8yrs |
CEO ownership | n/a |
Management average tenure | 1.8yrs |
Board average tenure | 3.4yrs |
Recent management updates
Recent updates
Alvotech's Position In The Coming Biosimilar Gold Rush
Nov 21Alvotech: Steady Progress Offers A Good Chance Of Upside
Aug 26Bullish: Analysts Just Made A Huge Upgrade To Their Alvotech (NASDAQ:ALVO) Forecasts
May 28Alvotech: Consider Buying As Positive Q1 Earnings Release Likely
Apr 25Alvotech (NASDAQ:ALVO) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely
Apr 03Alvotech (NASDAQ:ALVO) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?
Mar 24Analysts Just Shaved Their Alvotech (NASDAQ:ALVO) Forecasts Dramatically
Sep 03Positive Sentiment Still Eludes Alvotech (NASDAQ:ALVO) Following 27% Share Price Slump
May 05Shareholders Shouldn’t Be Too Comfortable With Alvotech's (NASDAQ:ALVO) Strong Earnings
Nov 23Fuji Pharma files for approval of biosimilar candidate in Japan
Oct 17Alvotech and STADA launch Humira biosimilar in Switzerland
Sep 22CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$441m |
Jun 30 2024 | n/a | n/a | -US$618m |
Mar 31 2024 | n/a | n/a | -US$494m |
Dec 31 2023 | US$2m | US$1m | -US$552m |
Sep 30 2023 | n/a | n/a | -US$596m |
Jun 30 2023 | n/a | n/a | -US$416m |
Mar 31 2023 | n/a | n/a | -US$713m |
Dec 31 2022 | US$740k | n/a | -US$514m |
Compensation vs Market: Robert's total compensation ($USD1.52M) is below average for companies of similar size in the US market ($USD6.56M).
Compensation vs Earnings: Robert's compensation has increased whilst the company is unprofitable.
CEO
Robert Wessman (54 yo)
1.8yrs
Tenure
US$1,517,000
Compensation
Mr. Robert Wessman serves as Chief Executive Officer of Alvotech since January 1, 2023. He Founded Alvotech in 2013 and serves as its Executive Chairman and Member of the Board of Directors since January 2...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, Founder & Executive Chairman | 1.8yrs | US$1.52m | no data | |
COO & Director | 1.2yrs | no data | 0% $ 0 | |
Chief Financial Officer | 4.8yrs | no data | 0.032% $ 1.2m | |
Chief Technical Officer | no data | no data | no data | |
Chief Scientific Officer | 5.1yrs | no data | 0.051% $ 1.8m | |
VP of Investor Relations and Global Communications | no data | no data | no data | |
General Counsel | 1.8yrs | no data | 0% $ 0 | |
Vice President of People & Culture | less than a year | no data | no data | |
Chief Commercial Officer | 6.3yrs | no data | no data | |
Chief Strategy Officer | 4.8yrs | no data | no data | |
Chief Quality Officer | less than a year | no data | no data | |
Chief Regulatory Affairs Officer | less than a year | no data | no data |
1.8yrs
Average Tenure
48yo
Average Age
Experienced Management: ALVO's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, Founder & Executive Chairman | 5.8yrs | US$1.52m | no data | |
COO & Director | 4.4yrs | no data | 0% $ 0 | |
Director | no data | no data | no data | |
Independent Non-Executive Director | 2.4yrs | US$81.00k | 0.0035% $ 126.9k | |
Non-Executive Director | 2.4yrs | US$71.00k | 0.0035% $ 126.9k | |
Non-Executive Director | 5.8yrs | no data | no data | |
Non-Executive Director | 2.4yrs | no data | no data | |
Independent Non-Executive Deputy Chairman | 5.8yrs | US$156.00k | 0.35% $ 12.6m | |
Independent Non-Executive Director | 2.4yrs | US$113.00k | 0.0035% $ 126.9k |
3.4yrs
Average Tenure
57yo
Average Age
Experienced Board: ALVO's board of directors are considered experienced (3.4 years average tenure).